MYELODYSPLASTIC SYNDROME

Known as: Myelodysplastic Syndromes, Myelodysplastic Syndromes [Disease/Finding], Myelodysplastic Syndrome/Neoplasm 
A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Genomic analysis has greatly influenced the diagnosis and clinical management of patients affected by diverse forms of… (More)
  • table 1
  • table 2
  • table 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
The International Prognostic Scoring System (IPSS) is an important standard for assessing prognosis of primary untreated adult… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Myelodysplastic syndromes are clinically heterogeneous disorders characterized by clonal hematopoiesis, impaired… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Drug treatments for patients with high-risk myelodysplastic syndromes provide no survival advantage. In this trial, we… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Aberrant DNA methylation, which results in leukemogenesis, is frequent in patients with myelodysplastic syndromes (MDS… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Ineffective erythropoiesis is the hallmark of myelodysplastic syndromes. Management of the anemia caused by… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in… (More)
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE Patients with high-risk myelodysplastic syndrome (MDS) have high mortality from bone marrow failure or transformation to… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Despite multiple disparate prognostic risk analysis systems for evaluating clinical outcome for patients with myelodysplastic… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1982
Highly Cited
1982
New diagnostic criteria for the diagnosis of the various myelodysplastic syndromes (MDS) are proposed, and a detailed description… (More)
Is this relevant?